Product Portfolio
2026 – 2027
2026 – 2027
Licensing opportunities — contact us for partnering enquiries
| Product | Dossier Ready | Countries Available |
|---|---|---|
|
Adenosine
3 mg/ml · 2 ml vials
|
Ready | Available outside Portugal, Poland, Hungary, Malta, Cyprus, UK & France |
|
Lymecycline capsules
150 mg · 300 mg
|
Ready | Available outside Nordics & UK |
|
Clonidine oral solution
10 mcg/ml
|
Q3 / 2026 | Available outside UK, ANZA & Canada |
|
Methenamine tablets
1 g
|
Q4 / 2026 | Available outside Nordics, UK, ANZA & Canada |
|
Tizanidine tablets
2 mg · 4 mg
|
Q4 / 2026 | Available outside UK, ANZA & Canada |
|
Bumetanide tablets
1 mg · 5 mg
|
Q1 / 2027 | Available outside Nordics, UK, ANZA, Netherlands & Canada |
|
Levodopa / Benserazide tablets
12.5 mg / 50 mg · 25 mg / 100 mg · 50 mg / 200 mg
|
Q1 / 2027 | Available outside Nordics, UK, ANZA & Canada |